Lixisenatide, a GLP-1R agonist, reduces neurofibrillary tangles and amyloid plaque load, and thereby ameliorates learning memory deficits in APP/PS1 mice (144, 157)
Epilepsy treatment
Stool cultures for bacterial, parasitic and viral pathogens including Salmonella, Shigella, Campylobacter, Yersinia, Vibrio, Aeromonas, Clostridium difficile, rotavirus, norovirus, Escherichia coli O157:H7/shiga toxin, Cryptosporidium, Giardia must be done
Further reciprocal mutagenesis studies will be required to identify key interactions responsible for the contrasting effects of exendin-phe1, exendin-asp3 and other analogs, facilitating future design of agonists with even greater selectivity
For these reasons, the success stories you may read in relation to these GLP-1 patches are likely due to a placebo effect, where your health improves when you receive an inactive medication because you believe it to be active, or because of other lifestyle changes, such as improving your diet or taking part in more exercise
Garca-Velasco JA, Budding D, Campe H, et al